FAP is a prognostic marker, but not a viable therapeutic target for clinical translation in HNSCC
ConclusionAlthough FAP+ CAFs have attracted increasing attention for their role in cancer, the feasibility and efficacy of FAP-targeting therapies for HNSCC remain doubtful.
Source: Cellular Oncology - Category: Cancer & Oncology Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Genetics | Head and Neck Cancer | HNSCC | Immunotherapy | Skin Cancer | Squamous Cell Carcinoma